title: Cardiovascular disease in CKD in 2013: Reducing cardiovascular risk--light at the end of the tunnel.
abstract: During 2013, a meta-analysis provided evidence that cystatin C improves estimated glomerular filtration rate in cardiovascular risk categorization in chronic kidney disease (CKD). Another study showed that low diastolic blood pressure (DBP) is harmful in patients with CKD, challenging the paradigm of treating elevated systolic blood pressure regardless of DBP. Overall, mortality rates in CKD have decreased but further improvement is required.
authors: Denver Health Medical Center, Denver, 660 Bannock Street, Mail Code 4000, Denver, CO 80204, USA.
authors: Jessica
authors: J
authors: Kendrick
authors: Division of Renal Diseases and Hypertension, University of Colorado Denver, 13199 East Montview Boulevard, Suite 495, Aurora, CO 80045, USA.
authors: Michel
authors: M
authors: Chonchol
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D018450:Disease Progression; D005919:Glomerular Filtration Rate; D006801:Humans; D015994:Incidence; D015995:Prevalence; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends
chemical_list: D002317:Cardiovascular Agents